ArticleFrontiers in neuroscience2026
A mechanistically informed framework of hierarchical temporal speech organization for objective differential assessment of motor speech disorders in neurodegenerative diseases.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Introduction: Speech is organized into discrete utterances and pauses in accordance with underlying linguistic structure, temporal coordination, prosodic organization, and respiratory demands. Temporal speech characteristics, including rhythmic and pausing patterns, are governed by multiple neurophysiological mechanisms and provide valuable insights for the assessment and management of motor speech disorders. This study employed a mechanistically informed analytic framework of hierarchical temporal speech organization to derive interpretable, objective measures for assessing rhythmic and pausing disturbances in neurodegenerative diseases. Methods: Orofacial kinematic and acoustic recordings were obtained from two neurodegenerative disease groups-amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD)-along with a neurologically healthy control (HC) group, during a passage reading task. Using automated analytic procedures, kinematic rhythm measures (movement-based) and acoustic rhythm measures (sound-based) were derived to characterize hierarchical rhythmic modulation of articulatory movements and critical-band acoustic modulation envelopes at prosodic, syllabic, and sub-syllabic levels. Pause measures were derived to characterize within- and between-sentence pausing patterns. Rhythmic and pausing patterns were compared across groups. The acoustically derived rhythm and pause measures were subsequently subjected to (1) discriminant analyses for multiclass classification among the ALS, PD, and HC groups, and (2) regularized regression models to evaluate their associations with functional outcomes. Results: Both neurodegenerative disease cohorts exhibited a reorganization of hierarchical rhythmic modulation characterized by reduced prosodic-level modulation and increased syllabic-level modulation. Such changes were, however, driven primarily by articulatory impairment in ALS and by respiratory-laryngeal impairment in PD. In addition, both cohorts showed reduced regularity of intra-syllabic temporal organization and altered within-sentence pausing patterns, whereas the ALS cohort exhibited additional changes in between-sentence pausing. Measures capturing these rhythmic and pausing disturbances demonstrated promising classification performance (mean accuracy = 0.77; mean area under the curve [AUC] = 0.84) and meaningful associations with functional speech decline across diseases. Discussion: The rhythm and pause measures captured disease-specific subclinical changes in the physiological substrates underlying rhythmic and pausing disturbances in ALS and PD, demonstrating potential as clinically applicable, objective markers to enable more accurate differential diagnosis, targeted intervention, and measurement-based care for neurodegenerative motor speech disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.